One dose of LSD provides weeks of anxiety relief, study finds
UC expert comments on new study to USA Today
The University of Cincinnati's Jeffrey Strawn was featured in a USA Today article commenting on a new study that found a pharmaceutical version of the psychedelic LSD might help alleviate anxiety symptoms for up to three months.
Study results were published Sept. 4 in the journal JAMA. The Phase 2, randomized clinical trial evaluated MM120, a pharmaceutical version of LSD, or lysergide D-tartrate, in 198 adults who had generalized anxiety disorder. After 12 weeks, anxiety symptoms improved in 65% of adults who took a single, 100-mg dose of the drug compared to 30.8% who took a placebo.
The study reported a "remission" rate of 47.5% among adults 12 weeks after taking a single dose compared to 20% who took a placebo. More than nine in 10 people on the 100-mg dose experience hallucinations, with other common side effects including nausea and headaches.
Strawn was not involved in the study, but oversees a clinical trial site for one of MM120's current Phase 3 studies. He said the study is "really important," as anxiety treatments have "really not significantly changed in decades."
"This is a disorder where often we are frustrated as clinicians marching through multiple treatments that don't work or produce side effects," Strawn, MD, professor in the Department of Psychiatry and Behavioral Neuroscience in UC’s College of Medicine and a UC Health child and adolescent psychiatrist, told USA Today. "Also, our patients are frustrated."
Featured photo at top of Dr. Strawn. Photo/Colleen Kelley/UC Marketing + Brand.
Related Stories
'Time is brain' again, now for control of intracerebral hemorrhage
February 5, 2026
MedPage Today highlighted research led by the University of Cincinnati's Joseph Broderick that found administering a synthetic protein can reduce bleeding and improve outcomes for certain patients at the highest risk of continued bleeding following a type of stroke called an intracerebral hemorrhage (ICH).
Children exposed to gambling mechanics before they understand money
February 4, 2026
Gambling-style mechanics are becoming a routine part of children’s digital lives, appearing in online games, mobile apps and even sports betting advertisements that surround popular media. University of Cincinnati experts warned in a recent WKRC-TV Local 12 report that long before children understand the value of money, they are learning the emotional highs and lows associated with risk. Online games, such as Roblox and Fortnite, offer fast-paced rewards that can keep children glued to screens.
Study: Synthetic protein potentially improves outcomes for certain subgroups following intracerebral hemorrhage
February 4, 2026
The University of Cincinnati’s Joseph Broderick, MD, presented results from the FASTEST trial at the International Stroke Conference, simultaneously published in The Lancet, that found administering a synthetic protein, recombinant Factor VIIa, can reduce bleeding and potentially improve outcomes for certain patients at the highest risk of continued bleeding following an intracerebral hemorrhage.